|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Harpoon Therapeutics Inc. (HARP)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-02-12 Purchase |
2019-02-14 6:01 pm |
Harpoon Therapeutics Inc. | HARP | Arix Bioscience plc Arix Bioscience Holdings Ltd 10% Owner |
428,571 | $14 | $5,999,994 | 2,892,119 (Indirect) |
View |
| 2019-02-12 Purchase |
2019-02-14 5:34 pm |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
250,000 | $14 | $3,500,000 | 3,898,422 (Direct) |
View |
| 2019-02-12 Sale |
2019-02-14 5:34 pm |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
447 | $14 | $6,258 | 3,898,422 (Direct) |
View |
| 2019-02-12 Purchase |
2019-02-14 5:33 pm |
Harpoon Therapeutics Inc. | HARP | New Leaf Ventures III L.P. New Leaf Venture Associates III L.P. New Leaf Venture Management III L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
428,571 | $14 | $5,999,994 | 2,242,839 (Indirect) |
View |
| 2019-02-12 Purchase |
2019-02-14 5:32 pm |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
250,000 | $14 | $3,500,000 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Sale |
2019-02-14 5:32 pm |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
1,524 | $14 | $21,336 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Purchase |
2019-02-14 5:30 pm |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
428,571 | $14 | $5,999,994 | 2,242,839 (Indirect Direct) |
View |
| 2019-02-12 Purchase |
2019-02-14 5:28 pm |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
500,000 | $14 | $7,000,000 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Sale |
2019-02-14 5:28 pm |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
1,971 | $14 | $27,594 | 8,422,847 (Indirect) |
View |
| 2018-11-09 Purchase |
2019-02-14 5:24 pm |
Harpoon Therapeutics Inc. | HARP | Chin Mark Director, 10% Owner |
428,571 | $14 | $5,999,994 | 2,892,119 (Indirect Direct) |
View |
| 2018-11-09 Purchase |
2019-02-14 5:19 pm |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
250,000 | $14 | $3,500,000 | 4,524,425 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-02-12 Conversion |
2019-02-14 6:01 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Arix Bioscience plc Arix Bioscience Holdings Ltd 10% Owner |
2,463,548 | $0 | 2,892,119 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 6:01 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Arix Bioscience plc Arix Bioscience Holdings Ltd 10% Owner |
1,720,698 | $0 | 2,892,119 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 6:01 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Arix Bioscience plc Arix Bioscience Holdings Ltd 10% Owner |
742,850 | $0 | 2,892,119 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:34 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
1,525,165 | $0 | 3,898,422 (Direct) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:34 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
1,578,755 | $0 | 3,898,422 (Direct) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:34 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
417,853 | $0 | 3,898,422 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:34 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
127,096 | $0.0492 | 3,898,422 (Direct) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:34 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
1,525,165 | $0 | 3,898,422 (Direct) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:34 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
1,578,755 | $0 | 3,898,422 (Direct) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:34 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
417,853 | $0 | 3,898,422 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:34 pm |
2016-11-01 2026-11-01 |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
76,258 | $0.0492 | 3,898,422 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:34 pm |
2017-01-10 2027-01-10 |
Harpoon Therapeutics Inc. | HARP | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC 10% Owner |
50,838 | $0.0492 | 3,898,422 (Direct) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:33 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | New Leaf Ventures III L.P. New Leaf Venture Associates III L.P. New Leaf Venture Management III L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
1,564,272 | $0 | 2,242,839 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:33 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | New Leaf Ventures III L.P. New Leaf Venture Associates III L.P. New Leaf Venture Management III L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:33 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | New Leaf Ventures III L.P. New Leaf Venture Associates III L.P. New Leaf Venture Management III L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:33 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | New Leaf Ventures III L.P. New Leaf Venture Associates III L.P. New Leaf Venture Management III L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
1,564,272 | $0 | 2,242,839 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:33 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | New Leaf Ventures III L.P. New Leaf Venture Associates III L.P. New Leaf Venture Management III L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:33 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | New Leaf Ventures III L.P. New Leaf Venture Associates III L.P. New Leaf Venture Management III L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:32 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
1,525,164 | $0 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:32 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
1,578,751 | $0 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:32 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
417,852 | $0 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:32 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
432,119 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:32 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
1,525,164 | $0 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:32 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
1,578,751 | $0 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:32 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
417,852 | $0 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:32 pm |
2015-03-24 2025-03-24 |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
25,418 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:32 pm |
2015-07-23 2025-07-23 |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
57,192 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:32 pm |
2015-08-19 2025-08-19 |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
171,579 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:32 pm |
2015-12-16 2025-12-16 |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
50,837 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:32 pm |
2016-11-01 2026-11-01 |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
76,256 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:32 pm |
2017-01-10 2027-01-10 |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd 10% Owner |
50,837 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:30 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
1,564,272 | $0 | 2,242,839 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:30 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:30 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2018-11-09 Purchase |
2019-02-14 5:30 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2018-11-09 Purchase |
2019-02-14 5:30 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2018-11-09 Option Award |
2019-02-14 5:30 pm |
N/A 2028-12-19 |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
20,335 | $2.12 | 2,242,839 (Direct) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:30 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
1,564,272 | $0 | 2,242,839 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:30 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:30 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | HUNT RONALD Director, 10% Owner |
464,281 | $0 | 2,242,839 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:28 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
3,050,329 | $0 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:28 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
3,157,506 | $0 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:28 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
835,705 | $0 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:28 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
559,215 | $0.0492 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:28 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
3,050,329 | $0 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:28 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
3,157,506 | $0 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Conversion |
2019-02-14 5:28 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
835,705 | $0 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:28 pm |
2015-03-23 2025-03-24 |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
25,418 | $0.0492 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:28 pm |
2015-07-23 2025-07-23 |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
57,192 | $0.0492 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:28 pm |
2015-08-19 2025-08-19 |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
171,579 | $0.0492 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:28 pm |
2015-12-16 2025-12-16 |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
50,837 | $0.0492 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:28 pm |
2016-11-01 2026-11-01 |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
152,514 | $0.0492 | 8,422,847 (Indirect) |
View |
| 2019-02-12 Exercise |
2019-02-14 5:28 pm |
2017-01-10 2027-01-10 |
Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT 10% Owner |
101,675 | $0.0492 | 8,422,847 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:24 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Chin Mark Director, 10% Owner |
1,720,698 | $0 | 2,892,119 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:24 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Chin Mark Director, 10% Owner |
742,850 | $0 | 2,892,119 (Indirect) |
View |
| 2018-11-09 Purchase |
2019-02-14 5:24 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Chin Mark Director, 10% Owner |
742,850 | $0 | 2,892,119 (Indirect) |
View |
| 2018-11-09 Option Award |
2019-02-14 5:24 pm |
N/A 2028-12-19 |
Harpoon Therapeutics Inc. | HARP | Chin Mark Director, 10% Owner |
20,335 | $2.12 | 2,892,119 (Direct) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:24 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Chin Mark Director, 10% Owner |
1,720,698 | $0 | 2,892,119 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:24 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Chin Mark Director, 10% Owner |
742,850 | $0 | 2,892,119 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:19 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
1,525,164 | $0 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:19 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
1,578,751 | $0 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:19 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
417,852 | $0 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Exercise |
2019-02-14 5:19 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
432,119 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Tax Withholding |
2019-02-14 5:19 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
1,524 | $14 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Purchase |
2019-02-14 5:19 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
417,852 | $0 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Option Award |
2019-02-14 5:19 pm |
N/A 2028-12-19 |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
20,335 | $2.12 | 4,524,425 (Direct) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:19 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
1,525,164 | $0 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:19 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
1,578,751 | $0 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Conversion |
2019-02-14 5:19 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
417,852 | $0 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Exercise |
2019-02-14 5:19 pm |
2015-03-24 2025-03-24 |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
25,418 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Exercise |
2019-02-14 5:19 pm |
2015-07-23 2025-07-23 |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
57,192 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Exercise |
2019-02-14 5:19 pm |
2015-08-19 2025-08-19 |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
171,579 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Exercise |
2019-02-14 5:19 pm |
2015-12-16 2025-12-16 |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
50,837 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Exercise |
2019-02-14 5:19 pm |
2016-11-01 2026-11-01 |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
76,256 | $0.0492 | 4,524,425 (Indirect) |
View |
| 2018-11-09 Exercise |
2019-02-14 5:19 pm |
2017-01-10 2027-01-10 |
Harpoon Therapeutics Inc. | HARP | EVNIN LUKE Director, 10% Owner |
50,837 | $0.0492 | 4,524,425 (Indirect) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Tue, 20 Aug 2019 00:30:56 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |